Advanced Medical Solutions Group plc · LSE:AMS
Advanced Medical Solutions — FY2000 Earnings Presentation
26 slides from Advanced Medical Solutions's earnings presentation, March 2001
Slide 1: Preliminary Results for year ended December 2000
3UHOLPLQDU\5HVXOWV IRU\HDUHQGHG'HFHPEHU 0DUFK
Slide 2: The plan for 2000
7KHSODQIRUZDV &RQWLQXDWLRQRIH[LVWLQJVWUDWHJ\ ± ZLWKWKHRYHUDOOREMHFWLYHRIPRYLQJWR SURILWDELOLW\ZLWKLQH[LVWLQJFDVK )RFXVRQVLJQLILFDQWO\UHGXFLQJRSHUDWLQJ ORVVDQGFDVKRXWIORZ ± 3URYLGHVWURQJILQDQFLDOSODWIRUPIRUJURZWK 'HYHORSSDUWQHUVKLSVZLWKPDMRUSOD\HUV 6WUHQJWKHQWHFKQRORJ\IRUIXWXUHYDOXH
Slide 3: Highlights
+LJKOLJKWV 7XUQRYHUXSE\WR P /RVVHVDOPRVWKDOYHGWR P &DVKRXWIORZUHGXFHGE\WR P %DODQFHVKHHWLPSURYHGZLWK PFDVKDW \HDUHQG )XUWKHUPDMRUSDUWQHUVKLSVIRUPHG 7HFKQRORJ\VWUHQJWKHQHGLQIRFXVDUHDVRI DFWLYHVGHOLYHU\DQGWLVVXHHQJLQHHULQJ
Slide 4: Sales and Net Loss
6DOHV1HW/RVV 0 $QQXDO6DOHV 1HW/RVV
Slide 5: Profit & Loss Account
3URILW /RVV$FFRXQW <HDUHQGHG <HDUHQGHG 'HFHPEHU 'HFHPEHU ¶ ¶ 7XUQRYHU *URVVSURILW ORVV 2SHUDWLQJORVV /RVVIRUWKHSHULRG /RVVSHUVKDUH S S UHVWDWHGLQFOXGLQJHIIHFWV RIULJKWVLVVXH
Slide 6: Balance Sheet
%DODQFH6KHHW $W $W 'HFHPEHU 'HFHPEHU ¶ ¶ )L[HGDVVHWV 6WRFN 'HEWRUV &UHGLWRUV :RUNLQJFDSLWDO 1HWFDVKGHEW (TXLW\VKDUHKROGHUV¶IXQGV
Slide 7: Cash Flow Statement
&DVK)ORZ6WDWHPHQW )RUWKH\HDU )RUWKH\HDU 'HFHPEHU 'HFHPEHU ¶ ¶ 1HWFDVKRXWIORZIURPRSHUDWLQJDFWLYLWLHV 1HWLQWHUHVWUHFHLYHG &DSLWDOH[SHQGLWXUH 1HWILQDQFLQJRIIL[HGDVVHWV 1HWIXQGVIURPULJKWVLVVXH 2WKHU 0RYHPHQWLQFDVK 1HWFDVKGHEWVWDUWRISHULRG 1HWFDVKGHEWDWHQGRISHULRG &DVKDWEDQN
Slide 8: Working Capital
:RUNLQJ&DSLWDO P <HDUV 'HEWRUV 6WRFN &UHGLWRUV :RUNLQJ&DSLWDO6DOHV
Slide 9: Cash Flow
&DVK)ORZ P 3URILW 'HSUHF &DSH[ :RUNLQJ&DSLWDO ,QWHUHVW 1HW
Slide 10: Strategy for growth
3URIHVVLRQDO:RXQGFDUH &RQVXPHU6NLQFDUH 6WUDWHJ\IRUJURZWK
Slide 11: Sales Growth
$GYDQFHG:RXQGFDUH 6DOHV*URZWK JURZWKRYHU 6DOHV P 3URIHVVLRQDO &RQVXPHU
Slide 12: Room to grow
5RRPWRJURZ $06 3URIHVVLRQDO &RQVXPHU &XVWRPHUV &XVWRPHUV 3KDUPDFLHV +RVSLWDOV 6XSHUPDUNHWV6KRSV 0LOOLRQ %LOOLRQ *URZLQJDW 7KH0DUNHW *URZLQJDW
Slide 13: Professional Wound Care Global Market
3URIHVVLRQDO:RXQGFDUH *OREDO0DUNHW 0DUNHWJURZWKUDWHV 5R: $OJLQDWH )RDPV 86$ +\GURJHO (XURSH +\GURFROORLG )LOP $GYDQFHG3URIHVVLRQDO:RXQGFDUHPDUNHW 0LOOLRQ
Slide 14: Relative market size: Consumer Skincare
&RQVXPHU6NLQFDUH 5HODWLYHPDUNHWVL]H 6SDLQ $XVWUDOLD $06SUHVHQFH %UD]LO ,WDO\ &DQDGD 6FDQGLQDYLD 6RXWK .RUHD )UDQFH 8. *HUPDQ\ -DSDQ 86$ $GYDQFHG&RQVXPHU:RXQGFDUHPDUNHW %LOOLRQ
Slide 15: Growth Strategy
*URZWK6WUDWHJ\ )RFXVRQWRSFXVWRPHUV FXVWRPHUVZLOO PDNHXSRI ± 3DUWQHUVKLS RXUVDOHVLQ ± 6HUYLFHH[FHOOHQFH 3DUWQHUPDMRUSOD\HUV ,PSURYH*URVV0DUJLQV /DXQFKHV ± 1HZSURGXFWV ± &XUUHQWUDQJHLQWRQHZPDUNHWV
Slide 16: Major players
0DMRUSOD\HUV 3URIHVVLRQDO:¶FDUH &RQVXPHU)LUVW$LG ± 61 LQF%HLHUVGRUI ± - -&RQVXPHU ± &RQYD7HF ± %HLHUVGRUI LQF61 ± - -0HGLFDO ± 1RYDUWLV ± 0 ± +DUWPDQ ± 0ROQO\FNH ± 0 ± &RORSODVW ± &DUULQJWRQ0HGOLQH &XUUHQW$063DUWQHU
Slide 17: Novartis
New from Savion LASTERS THAT ICTUALLY REDUCE Professional healing for the home ww. seavionfirstakco.uk
Slide 18: Novartis Germany / Novartis Switzerland
1RYDUWLV*HUPDQ\ 1RYDUWLV 1RYDUWLV6ZLW]HUODQG
Slide 19: Stops Bleeding gauze pads
Stops Bleeding ea two times faster Faster than regular gauze 6 Sterile Medium Gauze Pads 3.0 in. x 3.0 in. (7.6cm x 7.6cm)
Slide 20: Future value driver: New Materials Technology
)XWXUHYDOXHGULYHU 1HZ0DWHULDOV7HFKQRORJ\ ,QFOXGHDFWLYH LQJUHGLHQWV $FFHOHUDWHUHSDLURI WLVVXHV
Slide 21: Product Positioning
| product Positioning Barrier Drug hnol . Technology Delivery mam = Tissue Topical “— Epidermis Dermal Dernis Transdermal | | ny
Slide 22: New Materials Technology
1HZ0DWHULDOV7HFKQRORJ\ 0RYHIURP3DVVLYHWR$FWLYHSURGXFWV +HUEDODJHQWVDQWLVHSWLFV ± WHDWUHHRLODORHYHUD $QWLPLFURELDOVDQWLIXQJDOV ± LRGLQHVLOYHUFRSSHU 'UXJGHOLYHU\ ± 16$,'¶V &RPPHUFLDOSDUWQHUV
Slide 23: New Materials Technology
1HZ0DWHULDOV7HFKQRORJ\ &HOOILEUHLQWHUDFWLRQ :HWVSLQILEUHVRI%LRSRO\PHUV &RQVWUXFWILEUHVFDIIROGGHYLFHV $OORZVVWRUDJHUHOHDVHDQGSUHVHQWDWLRQRI ELRORJLFDOPROHFXOHV $FDGHPLFDQGFRPPHUFLDOSDUWQHUVLQSODFH 3DWHQWVILOHG
Slide 24: Prospects
3URVSHFWV 4WULQOLQHZLWKH[SHFWDWLRQV 2QFRXUVHWRUHDFKILQDQFLDOWDUJHWV &RQWLQXLQJWRGHYHORSSDUWQHUVKLSV ,QFUHDVHGRUGHUERRN &DSDFLW\RQO\DW ([SORULQJFRPSOHPHQWDU\WHFKQRORJLHV
Slide 25: Summary
6XPPDU\ $PRUHVHFXUHILQDQFLDOSODWIRUPKDVEHHQ HVWDEOLVKHGGXULQJ :HKDYHIRUPHGSDUWQHUVKLSVZLWKPDMRU JOREDOSOD\HUVWKDWFDQSURYLGHJURZWK 2XUWHFKQRORJ\KDVEHHQGHYHORSHGWR DOORZKLJKHUYDOXHSURGXFWVWREHGHOLYHUHG LQWKHIXWXUH
Slide 26: SUOHINIOS [DIP] POUEAD ESS
SUOHINIOS [DIP] POUEAD ESS
Advanced Medical Solutions Group — FY2000 Earnings Presentation on 6ix